## Abstract The original article to which this Erratum refers was published in International Journal of Cancer (2004) 110(3) 413–416DOI: 10.1002/ijc.20106
Smoking and the risk of breast cancer among carriers of BRCA mutations
✍ Scribed by Parviz Ghadirian; Jan Lubinski; Henry Lynch; Susan L. Neuhausen; Barbara Weber; Claudine Isaacs; Ruth-Gershoni Baruch; Susan Randall; Peter Ainsworth; Eitan Freidman; Douglas Horsman; Patricia Tonin; William D. Foulkes; Nadine Tung; Ping Sun; Steven A. Narod
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- French
- Weight
- 68 KB
- Volume
- 110
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The effect of cigarette smoking on the risk of breast cancer is controversial, although most studies show little or no effect. It has been suggested that smoking may reduce the risk of developing hereditary breast cancer. We completed a case‐control study on 1,097 women with breast cancer who were BRCA1 or BRCA2 mutation carriers and 1,097 age‐matched controls with a mutation in the same gene but without breast cancer. There were no statistically significant differences between the cases and controls in terms of the number of current and ex‐smokers (41.2% and 40.4%, respectively) or the age at smoking commencement (18.2 years and 18.5 years, respectively). There were no statistically significant differences between cases and controls regarding beginning smoking within 5 years of menarche (OR = 1.03; 95% CI 0.83 to l.28) or before the first pregnancy (OR = 1.09; 95% CI = 0.90 to 1.33). In conclusion, contrary to our previous report, smoking does not appear to be a risk factor for breast cancer among carriers of BRCA mutations. © 2004 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Although there are several plausible biologic mechanisms whereby coffee consumption might influence the risk of breast cancer, epidemiologic evidence is limited. We assessed the association between coffee consumption and breast cancer risk among high‐risk women who carry __BRCA__ mutati
## Abstract Early age at first birth and multiparity have been associated with a decrease in the risk of breast cancer in women in the general population. We examined whether this relationship is also present in women at high risk of breast cancer due to the presence of a mutation in either of the
## Abstract Age‐adjusted incidence rates of breast cancer vary more than 10‐fold worldwide, with the highest rates reported in North America and Europe. The highest breast cancer incidence rates in Southeast Asia have been reported for the Manila Cancer Registry in the Philippines, with an age‐stan
Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and ovarian cancer. A genome-wide association study (GWAS) identified six alleles associated with risk of ovarian cancer for women in the general population. We evaluated four of these loci as potential modifiers of
## Abstract Marked variation in phenotypic expression among __BRCA1__ and __BRCA2__ mutation carriers may be partly explained by modifier genes that influence mutation penetrance. Variation in CAG/CAA repeat lengths coding for stretches of glutamines in the C‐terminus of the AIB1 protein (amplified